SCHEMBL5794095

SCHEMBL5794095

COc1ccc(C2CCCCN2CC(=O)Oc2ccc(Cl)c(C(F)(F)F)c2)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
HCRTR1 O43613 2/20 0.42
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 2/20 0.41
USP2 O75604 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 5/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CFB P00751 1/20 0.39
KDM4E B2RXH2 1/20 0.39
OPRK1 P41145 3/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5796637 0.83 LMNA (0.59) SMN1; SMN2HCRTR1ALDH1A1LMNAMAPK1
SCHEMBL5820332 0.79 LMNA (0.54) SMN1; SMN2HCRTR1ALDH1A1LMNAMAPK1
SCHEMBL5794585 0.78 SMN1; SMN2 (0.44) SMN1; SMN2HCRTR1ALDH1A1LMNAMAPK1
SCHEMBL5806244 0.77 SMN1; SMN2 (0.43) SMN1; SMN2HCRTR1ALDH1A1LMNAMAPK1
SCHEMBL5795178 0.73 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1LMNAHTTNPSR1
SCHEMBL5793624 0.70 HCRTR1 (0.40) HCRTR1KDM4EATM
SCHEMBL5794482 0.70 MAPT (0.56) SMN1; SMN2HCRTR1ALDH1A1LMNAMAPK1
SCHEMBL12125064 0.70 MAPK1 (0.53) SMN1; SMN2ALDH1A1MAPK1MAPTCFB
SCHEMBL5796898 0.69 UTS2R (0.42) SMN1; SMN2ALDH1A1MAPK1HTTMAPT
SCHEMBL5793715 0.69 MAPT (0.47) SMN1; SMN2LMNACYP2D6CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006015279-A1 HETEROCYCLIC DIAMINE COMPOUNDS AS LIGANDS OF THE MELANIN CONCENTRATING HORMONE RECEPTOR USEFUL FOR THE TREATMENT OF OBESITY, DIABETES, EATING AND SEXUAL DISORDERS NEUROGEN CORPORATION (US) 2006-02-09 WO claimed